C, K., M, K., YC, C., A, K., DC, H., T, B., . . . L, B. (2024). NLGN4X TCR transgenic T cells to treat gliomas. Neuro-oncology, 26(2), 266. https://doi.org/10.1093/neuonc/noad172
Chicago Style (17th ed.) CitationC, Krämer, et al. "NLGN4X TCR Transgenic T Cells to Treat Gliomas." Neuro-oncology 26, no. 2 (2024): 266. https://doi.org/10.1093/neuonc/noad172.
MLA (9th ed.) CitationC, Krämer, et al. "NLGN4X TCR Transgenic T Cells to Treat Gliomas." Neuro-oncology, vol. 26, no. 2, 2024, p. 266, https://doi.org/10.1093/neuonc/noad172.
Warning: These citations may not always be 100% accurate.